New UCSF trial for GBM now open:

MedMaven

Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma | Brain Tumor Center

This phase II clinical trial will evaluate Ad-RTS-hIL-12 in combination with veledimex and cemiplimab-rwlc for treating patients with recurrent glioblastoma.

Comments

Brain

FEATURED

COMMUNITY

Overview of Brain Cancer

Symptoms, signs, diagnosis and overview of brain tumors.

Cancer Connect

The Treatment & Management of Brain Cancer

Cancer Connect - Treatment & Management of Brain Cancer

Cancer Connect

Pre-surgery Keytruda Immunotherapy Doubles Survival in Recurrent Glioblastoma

Research suggest immunotherapy may be effective treatment for glioblastoma.

MedMaven

Kinds of Brain Tumors and Cancers

Understand the various types, and the importance of "grade" in defining brain tumors.

Cancer Connect

Researchers Recruit Herpes Virus as Part of Brain Cancer Treatment

Researchers Recruit Herpes Virus as Part of Brain Cancer Treatment.

Cancer Connect

Rindopepimut with Temodar Appears Promising in Diagnosed Glioblastoma Multiforme

Rindopepimut with Temodar Appears Promising in Newly Diagnosed Glioblastoma Multiforme

Cancer Connect

MedMaven

Kimberly Fowler: Brain Cancer Survivor

Kimberly Fowler: Brain Cancer Survivor.

Cancer Connect

Food & Drug Administration Grants Orphan Drug Status for WP1066 in Glioblastoma

WP1066 for glioblastoma gets FDA orphan drug designation-Approvals in Nov 2020 for pediatric brain tumors.

MedMaven

Enzastaurin for Glioblastoma

Enzastaurin trial begins and other recent developments for treating Glioblastoma.

MedMaven

Strategies to Improve Treatment of Advanced Brain Cancers

CAR T cells engineered viruses, vaccines and immunotherapy are being developed for the treatment of primary brain cancer

MedMaven